CERVICAL CANCER RECURRENT
Clinical trials for CERVICAL CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new CERVICAL CANCER RECURRENT trials appear
Sign up with your email to follow new studies for CERVICAL CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough cervical cancers
Disease control Not yet recruitingThis study will observe 1,300 patients with advanced or recurrent cervical cancer who are treated with camrelizumab, famitinib, or combinations of these drugs. The goal is to see how safe and effective these treatments are in real-world settings. Patients are placed into one of s…
Matched conditions: CERVICAL CANCER RECURRENT
Sponsor: Qi Zhou • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New combo aims to tame advanced cervical cancer with fewer side effects
Disease control Not yet recruitingThis study tests three different doses of the drug famitinib combined with camrelizumab in 120 people with recurrent or metastatic cervical cancer that cannot be cured by standard treatments. The goal is to find a dose that keeps the cancer under control while causing fewer sever…
Matched conditions: CERVICAL CANCER RECURRENT
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC